XOMA Corp
NASDAQ:XOMA

Watchlist Manager

XOMA Corp

NASDAQ:XOMA

Watchlist

Discount Rate

Price: 25.28 USD -5.32% Market Closed

Updated: Jun 15, 2024

Have any thoughts about
XOMA Corp?

Write Note

Write Note Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Ask me anything about

XOMA Corp

What unique competitive advantages
does XOMA Corp hold over its rivals?

What risks and challenges
does XOMA Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of XOMA Corp.

What unique competitive advantages
does XOMA Corp hold over its rivals?

What risks and challenges
does XOMA Corp face in the near future?

Has there been any significant insider trading activity
in XOMA Corp recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for XOMA Corp.

Provide P/S
for XOMA Corp.

Provide P/E
for XOMA Corp.

Provide P/OCF
for XOMA Corp.

Provide P/FCFE
for XOMA Corp.

Provide P/B
for XOMA Corp.

Provide EV/S
for XOMA Corp.

Provide EV/GP
for XOMA Corp.

Provide EV/EBITDA
for XOMA Corp.

Provide EV/EBIT
for XOMA Corp.

Provide EV/OCF
for XOMA Corp.

Provide EV/FCFF
for XOMA Corp.

Provide EV/IC
for XOMA Corp.

Show me price targets
for XOMA Corp made by professional analysts.

What are the Revenue projections
for XOMA Corp?

How accurate were the past Revenue estimates
for XOMA Corp?

What are the Net Income projections
for XOMA Corp?

How accurate were the past Net Income estimates
for XOMA Corp?

What are the EPS projections
for XOMA Corp?

How accurate were the past EPS estimates
for XOMA Corp?

What are the EBIT projections
for XOMA Corp?

How accurate were the past EBIT estimates
for XOMA Corp?

Compare the revenue forecasts
for XOMA Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of XOMA Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of XOMA Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of XOMA Corp compared to its peers.

Compare the P/E ratios
of XOMA Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing XOMA Corp with its peers.

Analyze the financial leverage
of XOMA Corp compared to its main competitors.

Show all profitability ratios
for XOMA Corp.

Provide ROE
for XOMA Corp.

Provide ROA
for XOMA Corp.

Provide ROIC
for XOMA Corp.

Provide ROCE
for XOMA Corp.

Provide Gross Margin
for XOMA Corp.

Provide Operating Margin
for XOMA Corp.

Provide Net Margin
for XOMA Corp.

Provide FCF Margin
for XOMA Corp.

Show all solvency ratios
for XOMA Corp.

Provide D/E Ratio
for XOMA Corp.

Provide D/A Ratio
for XOMA Corp.

Provide Interest Coverage Ratio
for XOMA Corp.

Provide Altman Z-Score Ratio
for XOMA Corp.

Provide Quick Ratio
for XOMA Corp.

Provide Current Ratio
for XOMA Corp.

Provide Cash Ratio
for XOMA Corp.

What is the historical Revenue growth
over the last 5 years for XOMA Corp?

What is the historical Net Income growth
over the last 5 years for XOMA Corp?

What is the current Free Cash Flow
of XOMA Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for XOMA Corp.

XOMA

Balance Sheet

Total Liabilities & Equity

XOMA Corp
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

XOMA Corp
Total Liabilities & Equity Peer Comparison

Comparables:

ABBV

GILD

AMGN

VRTX

REGN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

	Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
XOMA Corp NASDAQ:XOMA	Total Liabilities & Equity $219.4m	CAGR 3-Years 22%	CAGR 5-Years 24%	CAGR 10-Years 7%
Abbvie Inc NYSE:ABBV	Total Liabilities & Equity $148.9B	CAGR 3-Years 0%	CAGR 5-Years 21%	CAGR 10-Years 18%
Gilead Sciences Inc NASDAQ:GILD	Total Liabilities & Equity $56.3B	CAGR 3-Years -6%	CAGR 5-Years -2%	CAGR 10-Years 7%
Amgen Inc NASDAQ:AMGN	Total Liabilities & Equity $93B	CAGR 3-Years 14%	CAGR 5-Years 8%	CAGR 10-Years 3%
Vertex Pharmaceuticals Inc NASDAQ:VRTX	Total Liabilities & Equity $23.9B	CAGR 3-Years 25%	CAGR 5-Years 30%	CAGR 10-Years 27%
Regeneron Pharmaceuticals Inc NASDAQ:REGN	Total Liabilities & Equity $34.4B	CAGR 3-Years 25%	CAGR 5-Years 22%	CAGR 10-Years 27%

What is XOMA Corp's Total Liabilities & Equity?

Total Liabilities & Equity
219.4m USD

Based on the financial report for Mar 31, 2024, XOMA Corp's Total Liabilities & Equity amounts to 219.4m USD.

What is XOMA Corp's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
7%

Over the last year, the Total Liabilities & Equity growth was 64%. The average annual Total Liabilities & Equity growth rates for XOMA Corp have been 22% over the past three years , 24% over the past five years , and 7% over the past ten years .

XOMA Corp
NASDAQ:XOMA

XOMA Corp
Total Liabilities & Equity

XOMA Corp
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

See Also

What is XOMA Corp's Total Liabilities & Equity?

Total Liabilities & Equity
219.4m USD

What is XOMA Corp's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
7%

Company

Help

Tools

Stocks

XOMA Corp NASDAQ:XOMA

XOMA Corp Total Liabilities & Equity

XOMA Corp Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis Latest Figures & CAGR of Competitors

See Also

What is XOMA Corp's Total Liabilities & Equity? Total Liabilities & Equity 219.4m USD

What is XOMA Corp's Total Liabilities & Equity growth rate? Total Liabilities & Equity CAGR 10Y 7%

Company

Help

Tools

Stocks

XOMA Corp
NASDAQ:XOMA

XOMA Corp
Total Liabilities & Equity

XOMA Corp
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

What is XOMA Corp's Total Liabilities & Equity?

Total Liabilities & Equity
219.4m USD

What is XOMA Corp's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 10Y
7%